1. Home
  2. JVA vs HOTH Comparison

JVA vs HOTH Comparison

Compare JVA & HOTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

JVA

Coffee Holding Co. Inc.

HOLD

Current Price

$4.47

Market Cap

17.8M

ML Signal

HOLD

Logo Hoth Therapeutics Inc.

HOTH

Hoth Therapeutics Inc.

HOLD

Current Price

$0.50

Market Cap

17.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
JVA
HOTH
Founded
1971
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Packaged Foods
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
17.8M
17.7M
IPO Year
1997
2018

Fundamental Metrics

Financial Performance
Metric
JVA
HOTH
Price
$4.47
$0.50
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$5.00
AVG Volume (30 Days)
232.1K
467.8K
Earning Date
03-16-2026
05-11-2026
Dividend Yield
1.81%
N/A
EPS Growth
N/A
29.69
EPS
0.29
N/A
Revenue
$90,655,294.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$15.24
N/A
Revenue Growth
17.54
N/A
52 Week Low
$2.93
$0.50
52 Week High
$5.62
$2.12

Technical Indicators

Market Signals
Indicator
JVA
HOTH
Relative Strength Index (RSI) 66.12 26.45
Support Level $4.02 $0.50
Resistance Level $4.78 $1.12
Average True Range (ATR) 0.24 0.07
MACD -0.01 -0.03
Stochastic Oscillator 72.73 4.95

Price Performance

Historical Comparison
JVA
HOTH

About JVA Coffee Holding Co. Inc.

Coffee Holding Co Inc is engaged in wholesale coffee operations, including manufacturing, roasting, packaging, marketing, and distributing roasted and blended coffees for privately labeled accounts and its brands, and it sells green coffee. The Company also manufactures and sells coffee roasters. Its products include wholesale green coffee, private-label coffee, and branded coffee. The company sells its coffee products throughout the United States, Canada, and certain Asian countries. The group's services are Custom Blending, Food Service Programs, and Private Label Services.

About HOTH Hoth Therapeutics Inc.

Hoth Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing new-generation therapies for unmet medical needs. It is focused on developing a topical formulation for treating side effects from drugs used for the treatment of cancer (HT-001); a treatment for mast-cell derived cancers and anaphylaxis (HT-KIT); and a treatment and/or prevention for Alzheimer's or other neuroinflammatory diseases (HT-ALZ). The company also has assets being developed for atopic dermatitis (also known as eczema) (BioLexa); a treatment for asthma and allergies using inhalational administration (HT-004); and an obesity treatment, and obesity-related diseases and conditions (HT-VA).

Share on Social Networks: